세계의 동물용 정형외과 의약품 시장 보고서(2025년)
Veterinary Orthopedic Medicine Global Market Report 2025
상품코드 : 1793443
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,493,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,386,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,279,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

동물용 정형외과 의약품 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에는 CAGR 8.6%를 나타내 56억 달러로 성장합니다. 예측기간의 성장은 골관절염의 유병률 증가, 반려동물 보험 도입 증가, 반려동물 비만의 높은 유병률, 반려동물 소유 증가, 반려동물 지출 증가로 인한 것입니다. 예측 기간의 주요 동향으로는 하이브리드 임플란트, 첨단 재료, 재생 의료, 3D 이미징, 컴퓨터 단층 촬영(CT) 등이 있습니다.

향후 5년간의 성장률 8.6%라는 예측은 이 시장에 관한 전회의 예측으로부터 변하지 않았습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 임플란트, 고정기구, 정형외과 수술 도구에 대한 관세는 수술 비용을 증가시키고 고급 정형외과 수술에 대한 접근을 감소시킬 수 있습니다. 또한 상호관세와 무역의 긴장과 한계 증가로 인한 세계경제와 무역에 대한 악영향으로 인해 그 영향이 더욱 광범위해질 것으로 보입니다.

반려동물 정형외과 질환의 이환율이 증가하면 동물용 정형외과 의약품 시장 성장을 가속할 것으로 예측됩니다. 반려동물 정형외과 질환은 동반 동물, 특히 개와 고양이의 근골격계에 영향을 미치는 질병을 의미합니다. 이러한 질병의 유병률 증가는 견종의 소인, 비만률 증가, 운동 부족과 영양 불량 등 환경의 영향 등의 요인에 기인하고 있습니다. 동물용 정형외과 의약품는 이러한 질병의 진단, 치료 및 관리에 중요한 역할을 하고, 통증을 완화하고, 운동 능력을 회복시키고, 반려동물의 삶의 질을 향상시키는 데 도움이 됩니다. 예를 들어, 2024년 7월 미국 비영리 단체인 Morris Animal Foundation의 보고서에 따르면 미국에서는 1,400만 마리 이상의 성견이 골관절염으로 고통받고 있다고 밝혔습니다. 게다가 12세 이상의 고양이의 약 90%에 변형성 관절증의 엑스레이 징후가 보인다는 데이터도 있어, 고령화된 반려동물에서 이 질환의 유병률의 높이가 강조되어, 치료법에 대한 인식과 진보의 필요성이 높아지고 있는 것이 부각되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Veterinary orthopedic medicine constitutes a distinct discipline within veterinary practice, concentrating on the identification, management, and prevention of musculoskeletal disorders and injuries in animals. This field encompasses a spectrum of conditions, including fractures, arthritis, congenital abnormalities, and soft tissue injuries, and entails diverse treatment modalities such as surgical procedures, physical therapy, and rehabilitation, all aimed at reinstating mobility and function in animals.

The primary products of veterinary orthopedic medicine include biologics, viscosupplements, and pharmaceuticals. Biologics are derived from living cells or organisms and are utilized to treat diseases or injuries in various animal species such as dogs, cats, horses, cattle, pigs, and others. These products find multiple applications, including the management of osteoarthritis, degenerative joint disease, joint inflammation or pain, and more, and are employed by veterinary hospitals, clinics, and other end-users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The veterinary orthopedic medicine market research report is one of a series of new reports from The Business Research Company that provides veterinary orthopedic medicine market statistics, including veterinary orthopedic medicine industry global market size, regional shares, competitors with veterinary orthopedic medicine market share, detailed veterinary orthopedic medicine market segments, market trends, and opportunities, and any further data you may need to thrive in the veterinary orthopedic medicine industry. This veterinary orthopedic medicine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The veterinary orthopedic medicine market size has grown strongly in recent years. It will grow from $3.69 billion in 2024 to $4.03 billion in 2025 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to emergence of regenerative medicine, telemedicine integration, increasing number of veterinary orthopedic specialists, rise in the adoption of viscosupplementation products, and improving animal health awareness.

The veterinary orthopedic medicine market size is expected to see strong growth in the next few years. It will grow to $5.6 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to rising prevalence of osteoarthritis, increasing adoption of pet insurance, high prevalence of obesity in companion animals, increasing pet ownership, rising pet expenditure. Major trends in the forecast period include hybrid implants, advanced materials, regenerative medicine, 3D imaging, computerized tomography (CT).

The forecast of 8.6% growth over the next five years remains unchanged from the previous projection for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Duties on implants, fixation devices, and orthopedic surgical tools could increase surgical costs and reduce access to advanced orthopedic procedures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising incidence of pet orthopedic diseases is expected to drive the growth of the veterinary orthopedic medicine market. Pet orthopedic diseases refer to conditions that affect the musculoskeletal system of companion animals, particularly dogs and cats. The increasing prevalence of these diseases can be attributed to factors such as breed predispositions, higher rates of obesity, and environmental influences like insufficient exercise and poor nutrition. Veterinary orthopedic medicine plays a critical role in diagnosing, treating, and managing these diseases, helping to alleviate pain, restore mobility, and enhance the overall quality of life for pets. For example, in July 2024, a report by the Morris Animal Foundation, a US-based non-profit organization, revealed that over 14 million adult dogs in the United States suffer from osteoarthritis. Furthermore, data shows that around 90% of cats over the age of 12 display radiographic signs of osteoarthritis, emphasizing the high prevalence of this condition in aging pets and highlighting the growing need for awareness and advances in treatment options.

Major companies in veterinary orthopedic medicine are increasingly investing in cutting-edge technologies, such as 3D printing labs for custom implants, regenerative medicine including stem cell and platelet-rich plasma (PRP) therapies, and advanced imaging techniques like MRI and CT scans specifically designed for animal patients. A 3D printing lab for pet orthopedic surgeries is a specialized facility that uses 3D printing technology to create custom implants, prosthetics, and surgical tools tailored for veterinary orthopedic procedures. For example, in October 2024, VCA Animal Hospitals, a U.S.-based provider of high-quality veterinary care for pets, launched a 3D printing lab at its VCA Northwest Veterinary Specialists facility in Clackamas, Oregon. This lab employs advanced 3D printing technology to enhance orthopedic surgeries by creating custom implants and surgical guides designed for each pet's unique anatomy. Osteoarthritis, which affects 20% of dogs older than one year and 80% of those over eight, often requires surgical intervention. By offering a personalized approach, VCA aims to promote faster recovery times and improve surgical outcomes, addressing complex orthopedic conditions more effectively than traditional methods.

In August 2022, Vimian Group AB, a Sweden-based veterinary health company, acquired Veterinary Orthopedic Implants, LLC (VOI) for USD 4.5 million. This acquisition allows Vimian Group AB to expand its presence and capabilities in the veterinary orthopedic sector by integrating VOI's specialized expertise and product portfolio. As a result, Vimian aims to enhance its ability to offer advanced orthopedic solutions and innovative implants to veterinary professionals worldwide, strengthening its position in the global veterinary health market. Veterinary Orthopedic Implants, LLC (VOI), a US-based company, specializes in the development and provision of a wide range of orthopedic implants.

Major companies operating in the veterinary orthopedic medicine market are AmerisourceBergen Corporation, Johnson & Johnson, EVEROST INC, Zoetis Inc., Elanco Animal Health, Integra lifesciences, Ceva Sante Animale, Virbac SA, STERIS Animal Health, Merck Animal Health (Merck & Co. Inc.), Veterinary Orthopedic Implants, American Regent, Bimeda U.S., B. Braun Melsungen AG, Coveto SA, Biogenesis Bago, Vetoquinol S.A., Avante Animal Health, Hyalogic LLC, Hester Biosciences, Petline Sa, Sklar Instruments, GerMedUSA, RWD Life Science, Orthomed (UK) Ltd, BioMedtrix LLC, IMEX Veterinary Inc.

North America was the largest region in the veterinary orthopedic medicine market in 2024. The regions covered in the veterinary orthopedic medicine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the veterinary orthopedic medicine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The veterinary orthopedic medicine market includes revenues earned by entities by providing services such as diagnosing, treating, and preventing musculoskeletal disorders and injuries in animals. The market value includes the value of related goods sold by the service provider or included within the service offering. The veterinary orthopedic medicine market also includes sales of external fixation devices, intramedullary devices, and joint implants. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Veterinary Orthopedic Medicine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on veterinary orthopedic medicine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for veterinary orthopedic medicine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The veterinary orthopedic medicine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Veterinary Orthopedic Medicine Market Characteristics

3. Veterinary Orthopedic Medicine Market Trends And Strategies

4. Veterinary Orthopedic Medicine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Veterinary Orthopedic Medicine Growth Analysis And Strategic Analysis Framework

6. Veterinary Orthopedic Medicine Market Segmentation

7. Veterinary Orthopedic Medicine Market Regional And Country Analysis

8. Asia-Pacific Veterinary Orthopedic Medicine Market

9. China Veterinary Orthopedic Medicine Market

10. India Veterinary Orthopedic Medicine Market

11. Japan Veterinary Orthopedic Medicine Market

12. Australia Veterinary Orthopedic Medicine Market

13. Indonesia Veterinary Orthopedic Medicine Market

14. South Korea Veterinary Orthopedic Medicine Market

15. Western Europe Veterinary Orthopedic Medicine Market

16. UK Veterinary Orthopedic Medicine Market

17. Germany Veterinary Orthopedic Medicine Market

18. France Veterinary Orthopedic Medicine Market

19. Italy Veterinary Orthopedic Medicine Market

20. Spain Veterinary Orthopedic Medicine Market

21. Eastern Europe Veterinary Orthopedic Medicine Market

22. Russia Veterinary Orthopedic Medicine Market

23. North America Veterinary Orthopedic Medicine Market

24. USA Veterinary Orthopedic Medicine Market

25. Canada Veterinary Orthopedic Medicine Market

26. South America Veterinary Orthopedic Medicine Market

27. Brazil Veterinary Orthopedic Medicine Market

28. Middle East Veterinary Orthopedic Medicine Market

29. Africa Veterinary Orthopedic Medicine Market

30. Veterinary Orthopedic Medicine Market Competitive Landscape And Company Profiles

31. Veterinary Orthopedic Medicine Market Other Major And Innovative Companies

32. Global Veterinary Orthopedic Medicine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Veterinary Orthopedic Medicine Market

34. Recent Developments In The Veterinary Orthopedic Medicine Market

35. Veterinary Orthopedic Medicine Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기